Antimicrobial resistance in bronchiectasis and cystic fibrosis varied widely in a study spanning 11 centers on 3 continents.

Imperial College London’s Jadwiga A. Wedzicha, MD, discusses anti-alarmin trial results in COPD and where biologics may fit ...

More than 4 in 5 patients with hand eczema referred for patch testing at a Shanghai dermatology hospital reacted to at least ...

An economic evaluation found nontargeted hepatitis C screening in emergency departments offered the greatest health benefit ...

The Community Oncology Alliance said final 2027 Medicare payment rules address longstanding gaps between hospital and ...

Experts break down the GOLD 2026 COPD guidelines, highlighting updates to diagnosis criteria, Group E risk categories, and nonpharmacologic interventions.

Pooled data on 2698 patients tie rituximab maintenance after bendamustine-rituximab to better PFS and OS in mantle cell lymphoma.

In 299 patients, more involved compartments were linked to higher complication risk after one-stage resection; 14.4% had ...

The planned separation would keep Aetna, CVS Caremark, and Oak Street Health together and move roughly 9000 drugstores into a ...

In a matched analysis of Epic COSMOS records, acoramidis was tied to an 18% lower composite risk and about 25% lower ...

A runner's death at the NYC marathon highlights how heat, dehydration, illness, drugs, and genetics can raise exertional ...

At AMCP Nexus 2026, experts discusse how drug pricing policy, AI, and high-cost cell and gene therapies may shape managed ...